Healthcare IT Today March 26, 2025
The following is a guest article by Josh Rosaasen, Chief Operating Officer at Locke Bio
The rise of direct-to-consumer (DTC) telehealth services has revolutionized how patients access medical care and prescriptions. Virtual consultations and digital pharmacies have provided unprecedented convenience, allowing patients to receive medications without in-person visits. However, this rapid growth has also led to increasing scrutiny from regulators aiming to balance accessibility with patient safety. Federal and state agencies, including the Drug Enforcement Administration (DEA) and the Food and Drug Administration (FDA), are shaping the future of telehealth through evolving policies.
As the sector adapts, telehealth providers must navigate new compliance challenges, particularly regarding controlled substances, data privacy, and multi-state licensing. Companies that integrate compliance-driven infrastructure can better...
Today's Sponsors
Today's Sponsor